Good News on Vaccine For 12-15 Age Group. Canada Approves Use

At this time of COVID crisis, Canada has announced its approval of administering the Pfizer-BioNTech Covid-19 vaccine to children ages 12 to 15 on Wednesday. Notably, Canada became the first country in the world to have okayed the two-dose Pfizer vaccine shots to the younger age group, according to Xinhua news agency.

“After completing a thorough and independent scientific review of the evidence, the department determined that this vaccine is safe and effective when used in this younger age group,” Health Canada’s Chief Medical Advisor Supriya Sharma said at a press conference on Wednesday.

Moreover, the Canadian government has also authorised the vaccine for use in individuals 16 years of age and older last December. Health Canada based its decision on data from Phase 3 clinical trial in participants aged 12 to 15 years old.

The trial enrolled 2,260 adolescents 12 to 15 years of age in the United States. All participants in the trial will continue to be monitored for long-term protection and safety for an additional two years after their second dose.

She also added that while the younger people are less likely to experience serious cases of Covid-19, having access to a safe and effective vaccine will help control the disease’s spread to their family and friends.